Home

UK, Aust to fast-track modified COVID jabs

AAP
Modified COVID vaccines "will not need a brand new approval or 'lengthy' clinical studies".
Camera IconModified COVID vaccines "will not need a brand new approval or 'lengthy' clinical studies".

Regulators in the UK, Australia and three other countries plan to fast-track the development of modified COVID-19 vaccines to ensure drug makers are able to move swiftly in targeting emerging variants of the disease.

Previously authorised vaccines that are modified to target new variants "will not need a brand new approval or 'lengthy' clinical studies", Britain's Medicines and Healthcare Products Regulatory Agency says.

The new guidance was issued jointly by regulators in the UK, Australia, Canada, Singapore and Switzerland. The guidelines build on the model already used to modify the flu vaccine in response to continual changes in that virus.

Under the new rules, developers will be required to provide "robust evidence" that modified COVID-19 vaccines produce a strong immune response to the variant, as well as data showing they are safe and meet quality standards.

"Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety," MHRA chief scientific officer Christian Schneider said on Thursday.

Get in front of tomorrow's news for FREE

Journalism for the curious Australian across politics, business, culture and opinion.

READ NOW

"Should any modifications to authorised COVID-19 vaccines be necessary, this regulatory approach should do that."

The announcement comes amid concerns that a variant first discovered in Brazil may be more resistant to existing vaccines than other variants.

Get the latest news from thewest.com.au in your inbox.

Sign up for our emails